🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of the study were: 1. To assess the safety and tolerability...
Status
Completed
Location
Allergy, Asthma and Immunology Associates
Start Date
2009-08-31
Trial ID
NCT00914966
Treatments Being Tested
This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expan...
Status
Active Not Recruiting
Location
AllerVie Clinical Research
Start Date
2022-02-15
Trial ID
NCT05121376
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
A new formulation of Berinert (CSL830) is being investigated for the manage...
Status
Completed
Location
Study Site
Start Date
2013-01
Trial ID
NCT01760343
This is a double-blind, randomized-withdrawal, placebo-controlled study in ...
Status
Terminated
Location
University of Alabama Hospital (at Birmingham)
Start Date
2017-11-06
Trial ID
NCT03221842
Treatments Being Tested
The main aim of this study is to describe the characteristics of participan...
Status
Completed
Location
Alberta Health Services
Start Date
2023-06-15
Trial ID
NCT05578417
Treatments Being Tested
The study objective was to determine the safety and efficacy of C1INH-nf fo...
Status
Completed
Location
Allergy and Immunology Associates
Start Date
2005-03-14
Trial ID
NCT01005888
Treatments Being Tested
This is an expanded access program (EAP) designed to allow access to deucri...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07759141
Treatments Being Tested
Hereditary angioedema ("HAE") is a disease characterized by recurrent tissu...
Status
Completed
Location
For information on sites, please contact Pharming Technologies
Start Date
2009-06
Trial ID
NCT00851409
Treatments Being Tested
The reason for this study is to see if the CD73 inhibitor LY3475070 alone o...
Status
Completed
Location
Sarah Cannon Research Institute at HealthOne
Start Date
2020-01-16
Trial ID
NCT04148937
Treatments Being Tested